Oncodesign Precision Medicine (FRA:ZR8) Days Inventory: 1,661.47 (As of Dec. 2025)


FRA:ZR8 Oncodesign Precision Medicine SA FRA:ZR8
38 GF Score
Price €0.30
GF Value €0.26
Valuation Modestly Overvalued
! 1 Warning Sign
View Full Analysis

What is Oncodesign Precision Medicine Days Inventory?

Oncodesign Precision Medicine FRA:ZR8 38 Days Inventory is 1,661.47 as of Dec. 2025. GuruFocus rates FRA:ZR8 with a GF Score™ of 38/100 and a GF Value™ of €0.26 (Modestly Overvalued). The stock has 1 warning sign investors should review. Among 638 Biotechnology companies, Oncodesign Precision Medicine ranks worse than 156739.66% on this metric.

Days Inventory is also known as Days Sales of Inventory (DSI). Oncodesign Precision Medicine's Average Total Inventories for the six months ended in Dec. 2025 was €11.74 Mil. Oncodesign Precision Medicine's Cost of Goods Sold for the six months ended in Dec. 2025 was €1.29 Mil. Hence, Oncodesign Precision Medicine's Days Inventory for the six months ended in Dec. 2025 was 1,661.47.

The historical rank and industry rank for Oncodesign Precision Medicine's Days Inventory or its related term are showing as below:

FRA:ZR8's Days Inventory is not ranked *
in the Biotechnology industry.
Industry Median: 183.195
* Ranked among companies with meaningful Days Inventory only.

Oncodesign Precision Medicine's Days Inventory increased from Dec. 2024 (0.00) to Dec. 2025 (1,661.47). It might indicate that Oncodesign Precision Medicine's sales slowed down.

Inventory Turnover measures how fast the company turns over its inventory within a year. Oncodesign Precision Medicine's Inventory Turnover for the six months ended in Dec. 2025 was 0.11.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Oncodesign Precision Medicine's Inventory-to-Revenue for the six months ended in Dec. 2025 was 98.61.

Oncodesign Precision Medicine  (FRA:ZR8) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Oncodesign Precision Medicine's Inventory Turnover for the six months ended in Dec. 2025 is calculated as

Inventory Turnover=Cost of Goods Sold / Average Total Inventories
=1.289 / 11.735
=0.11

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Oncodesign Precision Medicine's Inventory to Revenue for the six months ended in Dec. 2025 is calculated as

Inventory-to-Revenue=Average Total Inventories / Revenue
=11.735 / 0.119
=98.61

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

Oncodesign Precision Medicine Days Inventory Related Terms

Oncodesign Precision Medicine Days Inventory Historical Data

* Premium members only.

The historical data trend for Oncodesign Precision Medicine's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oncodesign Precision Medicine Days Inventory Chart

Oncodesign Precision Medicine Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Days Inventory
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Oncodesign Precision Medicine Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Days Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 1,661.47

FRA:ZR8 vs VRTX, REGN, ALNY: Days Inventory Comparison

For the Biotechnology subindustry, Oncodesign Precision Medicine's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oncodesign Precision Medicine Days Inventory vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oncodesign Precision Medicine's Days Inventory distribution charts can be found below:

* The bar in red indicates where Oncodesign Precision Medicine's Days Inventory falls into.


FRA:ZR8
38GF Score
Oncodesign Precision Medicine SA FRA:ZR8
Days Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Oncodesign Precision Medicine Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Oncodesign Precision Medicine's Days Inventory for the fiscal year that ended in Dec. 2025 is calculated as

Days Inventory (A: Dec. 2025 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (A: Dec. 2024 ) + Total Inventories (A: Dec. 2025 )) / count ) / Cost of Goods Sold (A: Dec. 2025 )*Days in Period
=( (0 + 10.47) / 1 ) / -9.47*365
=10.47 / -9.47*365
=N/A

Oncodesign Precision Medicine's Days Inventory for the quarter that ended in Dec. 2025 is calculated as:

Days Inventory (Q: Dec. 2025 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (Q: Jun. 2025 ) + Total Inventories (Q: Dec. 2025 )) / count ) / Cost of Goods Sold (Q: Dec. 2025 )*Days in Period
=( (13 + 10.47) / 2 ) / 1.289*365 / 2
=11.735 / 1.289*365 / 2
=1,661.47

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Inventory →
What does a Days Inventory of 1,661.47 mean?
Oncodesign Precision Medicine (FRA:ZR8) has a Days Inventory of 1,661.47 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Oncodesign Precision Medicine and its competitors. According to the industry distribution chart, Oncodesign Precision Medicine ranks #999999 out of 638 companies in the Biotechnology industry.
Is Oncodesign Precision Medicine's Days Inventory too high?
Oncodesign Precision Medicine's current Days Inventory is 1,661.47. The Biotechnology industry median Days Inventory is 183.20. Oncodesign Precision Medicine's value of 1,661.47 is 806.9% above this industry median. Based on the distribution chart, Oncodesign Precision Medicine ranks #999999 out of 638 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Oncodesign Precision Medicine has a GF Score™ of 38/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Oncodesign Precision Medicine's Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Oncodesign Precision Medicine ranks #999999 out of 638 companies for Days Inventory. This places Oncodesign Precision Medicine in the lower half of its industry. The industry median Days Inventory is 183.20. Oncodesign Precision Medicine's value of 1,661.47 is 806.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.20, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Oncodesign Precision Medicine's current Days Inventory of 1,661.47 is 806.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Oncodesign Precision Medicine and its competitors. For the Biotechnology industry, the median Days Inventory is 183.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Oncodesign Precision Medicine's current Days Inventory is 1,661.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oncodesign Precision Medicine stock overvalued right now?
Based on GuruFocus' analysis, Oncodesign Precision Medicine (FRA:ZR8) is currently considered Modestly Overvalued. The stock's GF Value™ is €0.26, compared to a current price of €0.30 — trading 16.9% above its estimated fair value. The current Days Inventory is 1,661.47 and 806.9% above the Biotechnology industry median of 183.20. Oncodesign Precision Medicine's overall GF Score™ is 38/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Oncodesign Precision Medicine (FRA:ZR8), the current Days Inventory is 1,661.47 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Oncodesign Precision Medicine (FRA:ZR8) Overvalued in 2026?

Based on GuruFocus' analysis, Oncodesign Precision Medicine stock appears to be overvalued. The current stock price of €0.30 is trading 16.9% above its estimated GF Value™ of €0.26. GuruFocus considers Oncodesign Precision Medicine to be Modestly Overvalued.

Key valuation signals for FRA:ZR8:

  • Days Inventory: 1,661.47
  • GF Value™: €0.26 vs. price of €0.30 (16.9% above fair value)
  • GF Score™: 38/100 with 1 warning sign
  • Industry Position: 806.9% above the Biotechnology median (#999999 of 638)

No single metric tells the full story. See the FRA:ZR8 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Oncodesign Precision Medicine Business Description

Other Exchanges ALOPM:France
Address 18 rue Jean Mazen, Dijon, FRA, 21000
Oncodesign Precision Medicine SA is a biopharmaceutical company specialised in precision medicine. Its mission is to provide patients with effective diagnostic and therapeutic solutions for resistant and metastatic cancers.
38GF Score

Get the complete analysis for FRA:ZR8

Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.30
Price
€0.26
GF Value